Insider Trading & Ownership - Smith Christopher M

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Smith Christopher M
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-01-03
Sale
2022-01-05
4:23 pm
Ortho Clinical Diagnostics Holdings plcOCDXSmith Christopher M
Chairman and CEO
100,000$21.1$2,109,8001,303,070
(Direct)
View
2021-08-02
Sale
2021-08-04
6:29 pm
Ortho Clinical Diagnostics Holdings plcOCDXSmith Christopher M
Chairman and CEO
270,000$21.82$5,890,487367,360
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-23
Option Award
2024-02-27
4:28 pm
N/A
2034-02-23
NEOGENOMICS INCNEOSmith Christopher M
Chief Executive Officer
632,419$02,487,303
(Direct)
View
2023-06-06
Exercise
2023-06-08
4:29 pm
N/A
N/A
QuidelOrtho CorpQDELSmith Christopher M
Director
2,248$035,577
(Direct)
View
2023-06-06
Option Award
2023-06-08
4:29 pm
N/A
N/A
QuidelOrtho CorpQDELSmith Christopher M
Director
2,248$035,577
(Direct)
View
2023-05-27
Tax Withholding
2023-05-31
4:05 pm
N/A
N/A
QuidelOrtho CorpQDELSmith Christopher M
Director
1,225$85.5433,329
(Direct)
View
2023-05-24
Option Award
2023-05-25
8:21 pm
N/A
N/A
QuidelOrtho CorpQDELSmith Christopher M
Director
2,898$02,898
(Direct)
View
2023-05-11
Option Award
2023-05-15
5:07 pm
N/A
2030-05-11
NEOGENOMICS INCNEOSmith Christopher M
Chief Executive Officer
558,221$01,854,884
(Direct)
View
2022-08-15
Option Award
2022-08-17
7:13 pm
N/A
2029-08-15
NEOGENOMICS INCNEOSmith Christopher M
Chief Executive Officer
1,296,663$01,296,663
(Direct)
View
2022-05-27
Option Award(A)
2022-08-01
7:17 pm
N/A
N/A
QuidelOrtho CorpQDELSmith Christopher M
Director
34,554$034,554
(Direct)
View
2022-06-23
Option Award
2022-06-27
5:05 pm
N/A
2032-06-22
Akouos Inc.AKUSSmith Christopher M
Director
16,000$016,000
(Direct)
View
2022-06-06
Option Award
2022-06-08
6:20 pm
N/A
N/A
QuidelOrtho CorpQDELSmith Christopher M
Director
2,248$02,248
(Direct)
View
2022-05-27
Option Award
2022-06-01
5:30 pm
N/A
2029-12-20
QuidelOrtho CorpQDELSmith Christopher M
Director
242,538$0242,538
(Direct)
View

Ownership
2022-06-01
4:59 pm
N/A
N/A
QuidelOrtho CorpQDELSmith Christopher M
Director
0$00
(Direct)
View
2022-05-27
Disposition
2022-06-01
4:15 pm
N/A
2029-12-20
Ortho Clinical Diagnostics Holdings plcOCDXSmith Christopher M
Chairman and CEO
2,338,780$00
(Direct)
View
2022-01-03
Exercise
2022-01-05
4:23 pm
N/A
2029-12-20
Ortho Clinical Diagnostics Holdings plcOCDXSmith Christopher M
Chairman and CEO
100,000$01,303,070
(Direct)
View
2022-01-03
Exercise
2022-01-05
4:23 pm
N/A
N/A
Ortho Clinical Diagnostics Holdings plcOCDXSmith Christopher M
Chairman and CEO
100,000$12.561,303,070
(Direct)
View
2021-06-24
Option Award
2021-06-25
4:35 pm
N/A
2031-06-23
Akouos Inc.AKUSSmith Christopher M
Director
16,000$016,000
(Direct)
View

Ownership
2021-01-27
9:10 pm
N/A
N/A
Ortho Clinical Diagnostics Holdings plcOCDXSmith Christopher M
Chairman and CEO
0$01,673,070
(Direct)
View

Ownership
2020-06-25
7:11 pm
N/A
N/A
Akouos Inc.AKUSSmith Christopher M
Director
0$039,030
(Direct)
View
(A) Indicate amendment filing.